PR News Wire…. BLUE BELL, Pa., Oct. 31, 2011 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), which is advancing synthetic vaccines to fight cancers and infectious diseases, announced today that VGX-3100, its investigational SynCon® vaccine for treating cervical dysplasia and cancer caused by human papillomavirus, was highlighted by Fierce Vaccines as one of 10 […]
Inovio reports sustained immune responses from cervical cancer DNA vaccine
Proactive Investors USA & Canada May 9, 2011 1:06 pm by Deborah Sterescu US-based vaccine maker Inovio Pharmaceuticals (AMEX:INO) reported Monday clinical data that showed the long-term immune responses induced by the company’s DNA vaccine for treating cervical dysplasia and cancer caused by HPV. Human papillomavirus (HPV) is a virus responsible for most cases of […]
Inovio Pharmaceuticals Receives Grant for Multi-Vaccine DNA Delivery
Inovio Pharmaceuticals Receives U.S. DOD Small Business Innovation Research Grant for Multi-Vaccine DNA Delivery Device Development BLUE BELL, Pa., March 21, 2011 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it has received a U.S. Department of […]
Inovio Pharmaceuticals Enters Phase II Clinical Trial with SynCon™ DNA Vaccine for Cervical Dysplasia Caused by HPV
BLUE BELL, Pa., Mar. 7, 2011 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that it is initiating a Phase II clinical trial for its VGX-3100 DNA vaccine for cervical dysplasia and cancer caused by human papillomavirus (HPV). […]
Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
Press Release by Inovio Pharmaceuticals BLUE BELL, Pa., Feb. 7, 2011 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of electroporation without contacting the […]